FIELD: chemistry.
SUBSTANCE: invention relates to cytotoxic compounds of directed action and methods for therapeutic use thereof in treating neoplasm and other diseases.
EFFECT: high treatment efficiency.
9 cl, 12 tbl, 31 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
| CHIMERIC EQUIVALENTS OF LIGANS OF SOMATOSTATIN AND DOPERMINE RECEPTORS, PHARMACEUTICAL COMPOSITIONS BASED ON THEM AND MODALTIES OF SOMATOSTATIN AND/DOPERMINE RECEPTORS | 2004 |
|
RU2329273C2 |
| CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| PEPTIDE DERIVATIVE, METHOD OF TREATMENT OF CANCER PATIENT | 1994 |
|
RU2133252C1 |
| SOMATOSTATIN AGONISTS | 2002 |
|
RU2259375C2 |
| LIGANDS OF MELANOCORTIN RECEPTORS | 2006 |
|
RU2401841C2 |
| APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY | 2008 |
|
RU2453328C2 |
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2439079C2 |
| PARAMINOHYPURIC ACID (PAH) AS A KIDNEY PROTECTOR | 2020 |
|
RU2804349C2 |
